Cargando…

Evaluation of Prothrombin Time and Activated Partial Thromboplastin Time in Hypertensive Patients Attending a Tertiary Hospital in Calabar, Nigeria

Introduction. Several biomedical findings have established the effects of hypertension on haemostasis and roles of blood coagulation products in the clinical course of hypertension. Methods. This cross-sectional study aimed at determining effects of hypertension on prothrombin time (PT) and activate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nnenna Adaeze, Nnamani, Uchenna Emeribe, Anthony, Abdullahi Nasiru, Idris, Babayo, Adamu, Uko, Emmanuel K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248403/ https://www.ncbi.nlm.nih.gov/pubmed/25477963 http://dx.doi.org/10.1155/2014/932039

Ejemplares similares

The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time
por: Samara, Evangelia, et al.
Publicado: (2021)

Molecular Detection and Clinical Implications of HTLV-1 Infections among Antiretroviral Therapy-Naïve HIV-1-Infected Individuals in Abuja, Nigeria
por: Nasir, Idris Abdullahi, et al.
Publicado: (2015)

Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population
por: Zhang, Fan, et al.
Publicado: (2022)

The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma
por: Geng, Chuanying, et al.
Publicado: (2021)

Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time
por: Kim, Sang-Min, et al.
Publicado: (2021)

Effect of storage conditions on prothrombin time, activated partial thromboplastin time and fibrinogen concentration on canine plasma samples
por: Piccione, Giuseppe, et al.
Publicado: (2010)

The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method
por: Hernaningsih, Yetti, et al.
Publicado: (2017)

Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients
por: Tekle, Esayas, et al.
Publicado: (2022)

Prothrombin Time and Activated Partial Thromboplastin Time Testing: A Comparative Effectiveness Study in a Million-Patient Sample
por: Capoor, Manu N., et al.
Publicado: (2015)

Activated Partial Thromboplastin Time or Prothrombin Time Prolongation During Rivaroxaban Administration: Clinical Risk Factors and Outcomes Analysis
por: Yuan, Yao, et al.
Publicado: (2023)

Survey of malaria and anti-dengue virus IgG among febrile HIV-infected patients attending a tertiary hospital in Abuja, Nigeria
por: Mustapha, Jelili Olaide, et al.
Publicado: (2017)

Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)
por: Zhang, Lin, et al.
Publicado: (2020)

Glutathione, glutathione peroxidase and some hematological parameters of HIV-seropositive subjects attending clinic in University of Calabar teaching hospital, Calabar, Nigeria
por: Coco-Bassey, Stephen Bassey, et al.
Publicado: (2019)

Exposure of Petrol Station Attendants and Auto Mechanics to Premium Motor Sprit Fumes in Calabar, Nigeria
por: Udonwa, N. E., et al.
Publicado: (2009)

Assessment of Stability of Prothrombin Time, International Normalized Ratio, and Activated Partial Thromboplastin Time Under Different Storage Conditions in Human Plasma
por: Patil, Parag, et al.
Publicado: (2022)

FRACTIONATION OF PLASMA GLOBULIN FOR PROTHROMBIN, THROMBOKINASE, AND ACCESSORY THROMBOPLASTIN
por: Milstone, J. H.
Publicado: (1951)

Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models
por: De Pablo-Moreno, Juan A., et al.
Publicado: (2022)

Pattern of pubertal changes in Calabar, South South Nigeria
por: Eyong, Michael Eteng, et al.
Publicado: (2018)

Effect of the reaction temperature on the prothrombin time and the apparent International Normalized Ratio determined with International Standards for thromboplastins
por: Van Den Besselaar, Antonius M. H. P., et al.
Publicado: (2021)

Sero-survey of measles virus antibodies among symptomatic children attending Abuja Teaching Hospital, Nigeria
por: Adekola, Hafeez Aderinsayo, et al.
Publicado: (2021)

International normalized ratio and activated partial thromboplastin time testing
por: Chornenki, Nicholas L. J., et al.
Publicado: (2022)

Perceptions of burden of caregiving by informal caregivers of cancer patients attending University of Calabar Teaching Hospital, Calabar, Nigeria
por: Akpan-Idiok, Paulina Ackley, et al.
Publicado: (2014)

Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen Reference Intervals for Inbred Strain 13/N Guinea Pigs (Cavia porcellus) and Validation of Low Volume Sample Analysis
por: Condrey, Jillian A., et al.
Publicado: (2020)

Comparative analysis on characteristics of two activated partial thromboplastin time reagents
por: Yasui, Yutaro, et al.
Publicado: (2022)

Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
por: Santoro, Rita Carlotta, et al.
Publicado: (2023)

Activated Partial Thromboplastin Time and Mortality in Coronary Artery Bypass Grafting Patients
por: Zhang, HuanRui, et al.
Publicado: (2022)

Clinical Significance of IgG Avidity Testing and Other Considerations in the Diagnosis of Congenital Cytomegalovirus Infection: A Review Update
por: Abdullahi Nasir, Idris, et al.
Publicado: (2016)

Phenotypic profile of pulmonary aspergillosis and associated cellular immunity among people living with human immunodeficiency virus in Maiduguri, Nigeria
por: Nasir, Idris Abdullahi, et al.
Publicado: (2019)

Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer
por: Bronić, Ana, et al.
Publicado: (2019)

Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values
por: Zhao, Ying, et al.
Publicado: (2011)

Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time
por: Spencer, Akpan, et al.
Publicado: (2011)

Coronary Artery Disease Presentation and Its Association with Shortened Activated Partial Thromboplastin Time
por: Sotoudeh Anvari, Maryam, et al.
Publicado: (2018)

Falsely prolonged activated partial thromboplastin time – a pre- and post-analytical issue
por: Gils, Charlotte, et al.
Publicado: (2018)

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform
por: Katayama, Haruna, et al.
Publicado: (2018)

Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy
por: Enko, Dietmar, et al.
Publicado: (2017)

Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria
por: Ekere, Ekerette Friday, et al.
Publicado: (2020)

Perinatal Outcome in Unbooked Teenage Pregnancies in the University of Calabar Teaching Hospital, Calabar, Nigeria
por: Iklaki, C. U., et al.
Publicado: (2012)

Activated partial thromboplastin time waveform analysis as specific sepsis marker in cardiopulmonary bypass surgery
por: Schneider, Christian P, et al.
Publicado: (2010)

A Patient with a Prolonged Activated Partial Thromboplastin Time and a Deep Intracerebral Haemorrhage
por: Schindhelm, Roger K., et al.
Publicado: (2012)

Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus
por: Sapkota, Binaya, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bqulrfpn858t7ac33v3ceb0d5p